本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trinity Biotech plc

7.33
-0.1450-1.94%
成交量:1.35萬
成交額:9.98萬
市值:595.60萬
市盈率:-0.12
高:7.77
開:7.77
低:7.17
收:7.47
52周最高:52.50
52周最低:6.85
股本:81.31萬
流通股本:66.91萬
量比:0.89
換手率:2.02%
股息:- -
股息率:- -
每股收益(TTM):-60.3628
每股收益(LYR):-60.3628
淨資產收益率:-1913.45%
總資產收益率:-5.72%
市淨率:-0.08
市盈率(LYR):-0.12

資料載入中...

2023/05/17

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/09/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/25

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/23

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/02

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/17

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/09/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]